Abstract
A study of palmitate oxidation in 200 consecutive human muscle biopsy specimens showed 14 patients in whom there was abnormal, incomplete palmitate oxidation when the rate of oxidation of palmitate14C (ul) was compared with that of palmitate14C (at carbon 1). Five patients had denervation as a primary diagnosis, and the remaining nine had a primary muscle disease. Of this latter group, six had clinical similarities, including proximal weakness, necrotic fibers on muscle biopsy, and extreme elevations of serum creatine kinase. With one exception, lipid storage was not part of the syndrome. The possibility of incomplete palmitate oxidation due to a defect in β-oxidation producing a human myopathy is discussed.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 561-564 |
| Number of pages | 4 |
| Journal | Archives of Neurology |
| Volume | 39 |
| Issue number | 9 |
| DOIs | |
| State | Published - Sep 1982 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
ASJC Scopus subject areas
- Arts and Humanities (miscellaneous)
- Clinical Neurology
Fingerprint
Dive into the research topics of 'Incomplete Palmitate Oxidation: Possible Source of Human Myopathy'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS